23andMe CEO Defends Practice Of Sharing Genetic Info With Pharma Companies

When it comes to health care, data is crucial. It’s already being used by companies like 23andMe, a genetic testing startup based in Mountain View, California.

The company is known for its $US99 genetic test kits that map out customers’ genomes and provide them with information about their ancestry.

In November 2013, the FDA barred 23andMe from sending its health reports to customers, because it was concerned that the company was misrepresenting genetic tests as medical advice, and worried customers would use that information to make medically unsound choices.

Hey, check out all the engineering jobs. Post your resume today!

Back to news